Epitomee Medical Ltd
Tel Aviv Stock Exchange EPIT.TA
Epitomee Medical Ltd Shares (Diluted, Weighted) for the year ending December 31, 2023: 29,595,824
Epitomee Medical Ltd Shares (Diluted, Weighted) is 29,595,824 for the year ending December 31, 2023, a 0.47% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
-
Epitomee Medical Ltd Shares (Diluted, Weighted) for the year ending December 31, 2022 was 29,457,627, a 1,575.26% change year over year.
-
Epitomee Medical Ltd Shares (Diluted, Weighted) for the year ending December 31, 2021 was 1,758,394, a -94.03% change year over year.
-
Epitomee Medical Ltd Shares (Diluted, Weighted) for the year ending December 31, 2020 was 29,456,600, a 0.00% change year over year.
-
Epitomee Medical Ltd Shares (Diluted, Weighted) for the year ending December 31, 2019 was 29,456,600.
Key data
| Date | Shares (Diluted, Weighted) | Revenue | Cost of Revenue | Gross Profit |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: EPIT.TA
| CEO | Dr. Radan Hashimshony Ph.D. |
| IPO Date | Dec. 15, 2021 |
| Location | Israel |
| Headquarters | 19 Tarshish |
| Employees | 42 |
| Sector | Health Care |
| Industries | |
Description
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email